These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 694839)

  • 1. Stimulation of platelet surface sialyltransferase activity by platelet aggregating agents.
    Wu KK; Ku CS
    Thromb Res; 1978 Aug; 13(2):183-92. PubMed ID: 694839
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet aggregation following exposure of phospholipase-treated platelet rich plasma to hydrogen peroxide.
    Iatridis SG; Iatridis PG; Kyrkou KA; Markidou SG; Iatridi IS
    Thromb Res; 1979; 15(5-6):733-41. PubMed ID: 494174
    [No Abstract]   [Full Text] [Related]  

  • 3. Glycoprotein-sialyltransferase activity of normal human, thrombasthenic and Bernard-Soulier platelets.
    Bauvois B; Cartron JP; Nurden A; Caen J
    Vox Sang; 1981 Feb; 40(2):71-8. PubMed ID: 6165143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet monoamine oxidase and epinephrine-induced platelet aggregation.
    Rossi EC; Louis G; Bieber M; Zeller EA
    Thromb Haemost; 1978 Aug; 40(1):37-42. PubMed ID: 725849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation by collagen or epinephrine of platelet responsiveness to aggregation. The possible role of substance(s) released from platelet membranes.
    Yoshida N; Aoki N
    J Lab Clin Med; 1977 Mar; 89(3):603-14. PubMed ID: 839118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell surface glycosyltransferases.
    Shur BD; Roth S
    Biochim Biophys Acta; 1975 Dec; 415(4):473-512. PubMed ID: 1106769
    [No Abstract]   [Full Text] [Related]  

  • 7. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
    Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
    Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced platelet sialyltransferase activity in patients with primary release disorder.
    Wu KK; Ku CS; Chen YC
    Lancet; 1980 Aug; 2(8192):441-3. PubMed ID: 6106096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of platelet aggregation and thromboxane B2 production during aspirin treatment: dependence on the dose of the aggregating agent.
    De Caterina R; Giannessi D; Gazzetti P; Bernini W
    Thromb Res; 1985 Jan; 37(2):337-42. PubMed ID: 3975876
    [No Abstract]   [Full Text] [Related]  

  • 10. Sex differences in the platelet response to aspirin.
    Coppe D; Wessinger SJ; Ransil BJ; Harris W; Salzman E
    Thromb Res; 1981 Jul 1-15; 23(1-2):1-21. PubMed ID: 7302916
    [No Abstract]   [Full Text] [Related]  

  • 11. Demonstration of endogenous sialyltransferase on the surface of ehrlich tumour ascites cells.
    Cerv'en E; Ronquist G; Agren G
    Ups J Med Sci; 1975; 80(1):58-60. PubMed ID: 1170667
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of N-acetylglucosamine and platelet inhibitors on the synergistic interaction of platelets and aggregating agents in the presence of wheat germ agglutinin.
    Tandon NN; Ordinas A; Jamieson GA
    Biochim Biophys Acta; 1982 Nov; 719(2):388-95. PubMed ID: 6817815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collagen-induced platelet aggregation: evidence of several mechanisms for the induction of platelet release by collagen.
    Nyman D
    Thromb Res; 1977 May; 10(5):743-51. PubMed ID: 882960
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of cyclooxygenase-independent platelet aggregation by low vitamin E concentration.
    Violi F; Pratico D; Ghiselli A; Alessandri C; Iuliano L; Cordova C; Balsano F
    Atherosclerosis; 1990 Jun; 82(3):247-52. PubMed ID: 2115784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in platelet surface sialytransferase activity and platelet aggregation in a group of cancer patients with a high incidence of thrombosis.
    Scialla SJ; Speckart SF; Haut MJ; Kimball DB
    Cancer Res; 1979 Jun; 39(6 Pt 1):2031-5. PubMed ID: 445401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosage frequency for suppression of platelet function by low dose aspirin therapy.
    Bradlow BA; Chetty N
    Thromb Res; 1982 Jul; 27(1):99-110. PubMed ID: 7123514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet responses to several agonists and combinations of agonists in whole blood: a placebo controlled comparison of the effects of a once daily dose of plain aspirin 300 mg, plain aspirin 75 mg and enteric coated aspirin 300 mg, in man.
    May JA; Heptinstall S; Cole AT; Hawkey CJ
    Thromb Res; 1997 Oct; 88(2):183-92. PubMed ID: 9361371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-bound and soluble platelet factor 4: effects of aggregating agents, of aggregation, and of aspirin.
    O'Brien JR; Finch W; Clark E
    Proc Soc Exp Biol Med; 1970 Sep; 134(4):1128-31. PubMed ID: 5457738
    [No Abstract]   [Full Text] [Related]  

  • 19. Cell surface changes in human normal and abnormal lymphoid cells detected by sialic acid content and sialyltransferase activity.
    Steimer F; Despont JP
    Leuk Res; 1980; 4(2):265-9. PubMed ID: 7412363
    [No Abstract]   [Full Text] [Related]  

  • 20. Sialyltransferase probing glycolytic energy metabolism in the plasma membrane.
    Cervén E; Ronquist G
    Naturwissenschaften; 1985 Feb; 72(2):86-8. PubMed ID: 3990825
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.